• human
  • Synthetic peptide derived from N-terminus of human Casein Kinase 1 gamma 2. (abcam.com)
  • Treatment with the COX2 inhibitor or knockdown of COX2 reduced expression of casein kinase (CK) 2 α, a phophorylated Akt and urokinase type plasminogen activator (uPA), resulting in p27 induction, cell cycle arrest at G1 phase and cell growth suppression in human urothelial carcinoma cell lines expressing COX2. (biomedcentral.com)
  • Furthermore
  • Furthermore, these growth factors can not abolish the inhibitory effects of CK-2 blockage on RPE cell proliferation. (arvojournals.org)
  • Therapeutics
  • Casein Kinase 2 Inhibitor - Pipeline Insight, 2018' reportoffers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Casein Kinase 2 Inhibitor development. (researchandmarkets.com)
  • Descriptive coverage of pipeline development activities for Casein Kinase 2 Inhibitor - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details. (researchandmarkets.com)